| scholarly article | Q13442814 |
| P50 | author | Li-Huei Tsai | Q9337816 |
| Kwanghun Chung | Q67218915 | ||
| Heejin Choi | Q90644372 | ||
| David A Bennett | Q66739430 | ||
| P2093 | author name string | Jun Wang | |
| Jennie Z Young | |||
| Ivana Delalle | |||
| Wen-Chin Huang | |||
| Christine G Yao | |||
| Fatema Abdurrob | |||
| Lauren Ashley Watson | |||
| Rebecca Gail Canter | |||
| Stephanie M Bousleiman | |||
| P2860 | cites work | Mamillary body in the rat: topography and synaptology of projections from the subicular complex, prefrontal cortex, and midbrain tegmentum | Q69225871 |
| The specificity of pH and ionic strength effects on the kinetics of the Rh (D)-anti-Rh (D) system | Q69989159 | ||
| Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model | Q24603560 | ||
| Thalamic pathology and memory loss in early Alzheimer's disease: moving the focus from the medial temporal lobe to Papez circuit | Q26748827 | ||
| Clarifying Tissue Clearing | Q26799523 | ||
| Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers | Q26825442 | ||
| Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
| Fiji: an open-source platform for biological-image analysis | Q27860912 | ||
| The brain's default network: anatomy, function, and relevance to disease | Q27860961 | ||
| Three dimensions of the amyloid hypothesis: time, space and 'wingmen' | Q28082768 | ||
| Monetary costs of dementia in the United States | Q28288245 | ||
| Simple, Scalable Proteomic Imaging for High-Dimensional Profiling of Intact Systems | Q28817946 | ||
| Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B | Q29012704 | ||
| Alzheimer's disease: the amyloid cascade hypothesis | Q29547160 | ||
| Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment | Q29547294 | ||
| Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease | Q29614374 | ||
| Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI | Q29619152 | ||
| Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease | Q30080016 | ||
| Chemogenetic inactivation of ventral hippocampal glutamatergic neurons disrupts consolidation of contextual fear memory | Q30407997 | ||
| Disruption of functional connectivity in clinically normal older adults harboring amyloid burden | Q30492809 | ||
| Amyloid beta from axons and dendrites reduces local spine number and plasticity. | Q30511922 | ||
| Seizures and epileptiform activity in the early stages of Alzheimer disease | Q30577633 | ||
| Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease | Q31142230 | ||
| Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration | Q33581412 | ||
| Early Brain Loss in Circuits Affected by Alzheimer's Disease is Predicted by Fornix Microstructure but may be Independent of Gray Matter | Q33672857 | ||
| Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia | Q33727909 | ||
| Advanced CLARITY for rapid and high-resolution imaging of intact tissues | Q33896353 | ||
| Single-cell phenotyping within transparent intact tissue through whole-body clearing | Q34127451 | ||
| Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease | Q34247849 | ||
| Alzheimer's disease: cell-specific pathology isolates the hippocampal formation | Q34261572 | ||
| The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study | Q34395540 | ||
| TeraStitcher - a tool for fast automatic 3D-stitching of teravoxel-sized microscopy images. | Q34488505 | ||
| Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease | Q34606557 | ||
| Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis | Q34717505 | ||
| Large-scale topology and the default mode network in the mouse connectome. | Q34830666 | ||
| Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. | Q34940642 | ||
| Neuronal activity regulates the regional vulnerability to amyloid-β deposition | Q35009626 | ||
| Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance | Q35227785 | ||
| Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression | Q35626520 | ||
| Aberrant functional connectivity in Papez circuit correlates with memory performance in cognitively intact middle-aged APOE4 carriers | Q35664370 | ||
| Progression of Seed-Induced Aβ Deposition within the Limbic Connectome | Q35931728 | ||
| Attenuation of β-Amyloid Deposition and Neurotoxicity by Chemogenetic Modulation of Neural Activity | Q36456728 | ||
| Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation | Q36556213 | ||
| β-amyloid, hippocampal atrophy and their relation to longitudinal brain change in cognitively normal individuals | Q36687792 | ||
| Memory retrieval by activating engram cells in mouse models of early Alzheimer's disease | Q36843600 | ||
| Amyloid deposition is associated with impaired default network function in older persons without dementia | Q37335603 | ||
| Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model | Q37341124 | ||
| Complement and microglia mediate early synapse loss in Alzheimer mouse models. | Q37391481 | ||
| How do mammillary body inputs contribute to anterior thalamic function? | Q38238305 | ||
| Distinct Neural Circuits for the Formation and Retrieval of Episodic Memories | Q38617186 | ||
| Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons | Q38727771 | ||
| The Cellular Phase of Alzheimer's Disease | Q38731102 | ||
| Gamma frequency entrainment attenuates amyloid load and modifies microglia | Q42631490 | ||
| Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment | Q44571913 | ||
| In vivo staging of regional amyloid deposition | Q47123732 | ||
| Chronic optogenetic activation augments aβ pathology in a mouse model of Alzheimer disease | Q47569266 | ||
| CIDRE: an illumination-correction method for optical microscopy | Q48216198 | ||
| Synapse loss in the temporal lobe in Alzheimer's disease | Q48338615 | ||
| In vivo and post-mortem memory circuit integrity in frontotemporal dementia and Alzheimer's disease | Q48362827 | ||
| Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. | Q48404445 | ||
| Dendritic structural degeneration is functionally linked to cellular hyperexcitability in a mouse model of Alzheimer's disease | Q48431425 | ||
| The fornix and mammillary bodies in older adults with Alzheimer's disease, mild cognitive impairment, and cognitive complaints: a volumetric MRI study | Q48442570 | ||
| Phases of A beta-deposition in the human brain and its relevance for the development of AD. | Q48567985 | ||
| Amyloid neuropathology in the single Arctic APP transgenic model affects interconnected brain regions | Q48924770 | ||
| Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity | Q48983820 | ||
| Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias | Q49039021 | ||
| A disproportionate role for the fornix and mammillary bodies in recall versus recognition memory. | Q51889738 | ||
| NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. | Q52589491 | ||
| Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. | Q53274559 | ||
| P304 | page(s) | 360 | |
| P577 | publication date | 2019-10-04 | |
| P1433 | published in | Communications Biology | Q60029756 |
| P1476 | title | 3D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice | |
| P478 | volume | 2 |
| Q92380837 | Tissue clearing and its applications in neuroscience | cites work | P2860 |
Search more.